Shox Deficiency

• CLINICAL_TRIALS research · 2026-02-27
  Clinical Trial Update: A Basket Study of Vosoritide in Children With Turner Syndrome, Short Stature Homeobox-Containing Gene Deficiency, and Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treatment [Phase 2]

  Recruitment is ongoing for a Phase 2 basket study evaluating Vosoritide in children with SHOX deficiency, Turner syndrome, or Noonan syndrom…

• FDA approval · 2020-01-08
  FDA Approved: GENOTROPIN — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

  The FDA approved Genotropin (somatropin) via a supplemental application submitted by Pfizer Laboratories Div Pfizer Inc.

• CLINICAL_TRIALS trial_result · 2010-12-20
  Clinical Trial Update: Somatropin Treatment in Patients With SHOX Deficiency and Turner Syndrome [Phase 3]

  Phase 3 clinical trial of somatropin in patients with SHOX deficiency and Turner syndrome has completed. Sponsored by Eli Lilly and Company.

• FDA approval · 2007-09-20
  FDA Approved: NORDITROPIN — Supplemental Application (Novo Nordisk)

  FDA approved a supplemental application for Norditropin (somatropin) from Novo Nordisk, indicating an approved update to the existing BLA.